The course will focus on the new aspects and methodological challenges of modern cancer clinical trials. The course will address new clinical trials features aimed at understanding the biology of the disease and document molecular determinants whether host or disease related which may be prognostic or /predictive of patient outcome. As innovative approaches will be discussed, attendees are expected to already have a good understanding of the basis of clinical trial methodology.